OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
OpGen, Inc. Announces $10 Million Private Placement Priced at the Market
OpGen Group Company Ares Genetics Commercially Launches NGS-based Antibiotic Resistance Testing Service for Native Specimens and Receives Bulk Order from Public Health Agency
OpGen Reports Third Quarter 2020 Financial Results and Provides Business Update

btn News

See All News

Upcoming Events
More events are coming soon.

btn Events

See all events